FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dimercaprol (Bal in Oil) Injection USP
Status: Currently in Shortage
»Date first posted: 05/11/2020
»Therapeutic Categories: Hematology; Other

Akorn Pharmaceuticals (Revised 09/16/2020)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
3 mL (100 mg/mL) ampules, box of 10 (NDC 17478-526-03) Product is currently on backorder. Estimated shortage duration is until November 2020. Estimated recovery 3Q2020

Extended Use Dates to Assist with Drug Shortages

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English